Role of Surgi-ORC in Postoperative Bleeding After Minor Oral Surgery in Cirrhosis Patients

Role of Surgi-ORC in Postoperative Bleeding After Minor Oral Surgery in Cirrhosis Patients

 Introduction

Minor oral surgery, a focused subspecialty of oral and maxillofacial surgery, encompasses procedures involving the teeth, gingiva, alveolar bone, and adjacent soft tissues.¹ These procedures such as tooth extractions, periodontal interventions, biopsies, and alveoloplasty are routinely performed to relieve pain, restore oral function, facilitate prosthetic rehabilitation, and aid in the diagnosis or management of infections and tumors.¹˒²

While minor oral surgical procedures are generally considered safe, postoperative bleeding remains one of the most frequent complications and is significantly increased in patients with liver cirrhosis due to impaired coagulation.

In such high-risk populations, achieving rapid and reliable local hemostasis is essential. Alongside systemic optimization, topical hemostatic agents play a critical role in minimizing postoperative bleeding and reducing procedure-related morbidity.

What challenges do surgeons face when performing oral surgery in patients with cirrhosis?

Oral surgery in patients with cirrhosis is challenging due to impaired coagulation (involves reduced clotting factors, thrombocytopenia, platelet dysfunction, and altered fibrinolysis), increased bleeding risk, susceptibility to infection and altered drug metabolism.2–5 Even minor procedures can lead to significant blood loss and complications. Therefore, rapid and effective hemostasis is critical, and oxidized regenerated cellulose (ORC)–based topical agents, such as Surgi-ORC®, provide reliable local bleeding control in these high-risk patients.

Next, let’s explore Surgi-ORC® in more detail and understand how it can support effective bleeding control in these patients.

What is Surgi-ORC®

Surgi-ORC® is a plant-based, absorbable hemostat made from oxidized regenerated cellulose. It does not interfere with healing and is commonly used in general surgery, post-extraction alveolitis (dry socket) and periodontal procedures. Surgi-ORC® is available in ORIGINAL/STANDARD, KNIT, FIBRIL and NON-WOVEN/SNOW forms.

Press enter or click to view image in full size
Figure 1: Surgi-ORC® absorbable hemostat (Oxidized Regenerated Cellulose)

How does Surgi-ORC® work at the bleeding site for such patients?


Managing bleeding in patients with cirrhosis can be challenging, and conventional methods like ligation are often ineffective or impractical. Surgi-ORC® offers a reliable solution by controlling bleeding through a physical effect without interfering with the body’s natural clotting process.

Press enter or click to view image in full size

These combined actions make Surgi-ORC®a reliable choice for controlling bleeding during minor oral procedures, with practical features that support safe and effective clinical use.

How Does Surgi-ORC® Achieve Hemostasis?

Surgi-ORC® is an absorbable topical hemostatic developed for rapid, localized control of bleeding from capillary, venous, and small arteriolar vessels. Its mechanism of action involves:

  • Absorbs blood and swell into brownish-black gelatinous mass, providing a protective barrier over the injury site
  • Creation of a localized low-pH environment that promotes vasoconstriction
  • Functioning as a matrix for platelet adhesion, thereby facilitating clot formation

What features make Surgi-ORC® clinically useful?

Surgi-ORC® offers several features that make it clinically useful, including:

Press enter or click to view image in full size

Together, these features make Surgi-ORC® a safe, effective, and user-friendly option for managing bleeding in such patients.

What does clinical evidence suggest about its effectiveness?

A prospective, randomized, single-blind study of 50 patients with cirrhosis undergoing minor oral surgery (40 teeth per group) reported comparable hemostatic efficacy for Surgicel® (oxidized regenerated cellulose) and Celox™ (chitosan-based agent), with mean hemostasis times of 2.94 and 3.38 minutes, respectively (p > 0.05). No platelet transfusions or material-related complications were observed, results indicating that both ORC and chitosan-based agent are safe and effective for bleeding control in such patients.4

Conclusion

Effective control of postoperative bleeding is critical in patients with cirrhosis to prevent complications and ensure safe outcomes. Surgi-ORC® is a reliable, user-friendly hemostatic agent with proven efficacy, enabling surgeons to achieve effective bleeding control and enhancing the safety of minor oral procedures.


Comments

Post a Comment

Popular posts from this blog

Revolutionizing Surgical Hemostasis: Introducing Surgi-ORC® Powder (Absorbable Hemostatic Powder)

Image
  In modern surgery, efficiently managing perioperative bleeding is crucial. Uncontrolled surgical bleeding poses significant risks to patient health and leads to substantial clinical and healthcare resource burdens. This challenge is particularly pronounced with an aging population and the rising prevalence of comorbidities and anticoagulant use. To address these issues, topical hemostatic agents have emerged as vital tools, promoting hemostasis where conventional methods fall short. These agents vary widely in properties, mode of action, ease of use, safety, and cost. Their selection often depends on the specific surgical scenario, bleeding situation, and patient’s health status. Exploring Topical Hemostatic Agents The current array of topical hemostatic agents comprises several types, each designed to meet different needs in the surgical setting: Mechanical Agents:  These are regarded as the simplest, safest, and most cost-effective. They offer a structural framework for he...
Read more

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he...
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba...
Read more